In several cancer cells, the expression, and the activity of ERRα, and its cofactor PGC-1, is further influenced by oncogenic signals (e.g., IGF1 receptor pathway, estrogen signaling, mTOR pathway) and induces metabolic programs favoring cell growth and tumor progression. The gene discussed is MTOR; the disease is neoplasm.